DaVita Inc.(0I7E)
USD --+0.00%
Reward51Moderate
Risk51Moderate
📊75%Data
0I7E
+0.0 · +0.00%
USD · LSE
DaVita Inc. |
Balanced
Market Cap:
ℹ️
Reward Rating
51
Moderate
Bottom 50% (model universe)
75% data coverage
ℹ️
Risk Rating
51
Moderate
Risk Assessment
ℹ️

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

ℹ️ Educational tool only · More
Limited data coverage
We don't have enough public data on 0I7E to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
Not available for limited-coverage stocks
The overview tab requires fundamentals and price history we don't have for this stock. The price chart is the most reliable view we have — try the Chart tab.

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

What is DaVita Inc.?

provides kidney dialysis services for patients suffering from chronic kidney failure in the United States.

0I7E · Verdict

Moderate reward · elevated risk

0I7E's standout is cash flow; valuation and balance sheet weigh on the picture.

Based on 88% data coverage

0I7E · Verdict

What’s working & what to watch

Strengths 1

  • Cash flow76/100

    10% free-cash-flow margin

Watchouts 2

  • Valuation33/100

    Below average

  • Balance sheet33/100

    Interest covered 3.5×

Model-based scoring. For information only — not financial advice.

What is DaVita Inc.?

provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. The company is listed on the LSE in UK, and a P/E ratio of 0.2x.

Financial Highlights

Investment Breakdown

📈 Growth
Moderate growth momentum — positive trajectory without breakout acceleration.
💰 Profitability
Adequate profitability with some margin variability in recent periods.
⚠️ Risk
Risk profile appears balanced versus broad market conditions.
💸 Valuation
Premium valuation reflects strong growth expectations already priced in.

OpenBook Logo Analysis

Reward: Moderate (51)

The scoring profile indicates limited reward potential at this time, with growth and profitability offering the most support. Risk indicators are elevated — volatility and macro sensitivity warrant consideration.

For informational purposes only. Not financial advice.

Company Information
SectorN/A
Market CapN/A
P/E Ratio0.1839
Dividend YieldN/A
52 Week High160
52 Week Low101.0131
Last AnnualDecember
IPO DateN/A
IncorporatedUK
Shares Outstanding166M
No. of Employees78,000
IndustryN/A
ExchangeLSE
Beta0.915
CurrencyUSD